ARTICLE | Clinical News
Axxess drug eluting stent regulatory update
August 9, 2010 7:00 AM UTC
Devax received CE Mark approval in the EU for its Axxess biolimus A9-eluting stent to treat coronary bifurcations. Devax has rights to biolimus A9 from Biosensors International Group Ltd. (SGX:B20, S...